Patent · US Active

Antibodies to ICOS

US10570203B2 · kind B2 · utility

1Cited by
20References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 20, 2018
Grant dateFeb 25, 2020
Priority date
Expiry dateAug 21, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2319/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are various embodiments relating to antibodies. Some of the embodiments include agonist antibodies that bind ICOS. Such antibodies can be used in methods to treat, for example, cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.